farnesol has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandes, NV; Jones, S; Katuru, R; Mo, H; Qu, H; Yeganehjoo, H; Yu, Z | 1 |
| Burke, YD; Crowell, PL; Roach, SL; Sen, SE; Stark, MJ | 1 |
2 other study(ies) available for farnesol and Carcinoma
| Article | Year |
|---|---|
β-ionone induces cell cycle arrest and apoptosis in human prostate tumor cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Cell Cycle Checkpoints; Cell Line, Tumor; Dose-Response Relationship, Drug; Farnesol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitory Concentration 50; Male; Norisoprenoids; Prostatic Neoplasms | 2013 |
Inhibition of pancreatic cancer growth by the dietary isoprenoids farnesol and geraniol.
Topics: Acyclic Monoterpenes; Animals; Antineoplastic Agents; Carcinoma; Cricetinae; Drug Screening Assays, Antitumor; Farnesol; Humans; Mesocricetus; Monoterpenes; Pancreatic Neoplasms; Terpenes; Tumor Cells, Cultured | 1997 |